medigraphic.com

2018, Number 4

<< Back Next >>

Enf Infec Microbiol 2018; 38 (4)

Melioidosis in pediatrics: potential agent of microbiological bioterrorism

López CG, López DAV, Reyes HKL, Reyes GU, Santos CLA, De Lara HJ, Quero HA, Matos ALJ, Martínez APA, Luevanos VA

Language: Spanish
References: 63
Page: 131-137
PDF size: 227.97 Kb.


ABSTRACT

Melioidosis is a tropical disease caused by the Gram-negative bacillus Burkholderia pseudomallei, transmitted by soil, is an endemic disease in northern Australia and Southeast Asia, and is currently recognized in non-endemic places, including Mexico. The genus Burkholderia comprises more than 40 species.
This is a review of elementary concepts for clinical suspicion and laboratory diagnosis, to establish an opportune treatment, given its high mortality. The clinical picture is very similar to tuberculosis, fulminant sepsis or rapidly progressive pneumonia. Because of its high lethality, there is a great risk that it would be used in bioterrorism.


REFERENCES

  1. Martínez-Hernández, L., González-Híjar, A., Valdez-Vásquez, R., García-López, S. y González-Chon, O., “Melioidosis: reporte de un caso y revisión de la literatura”, Neumol Cir Torax, 2013, 72 (4): 291-298.

  2. Sarovich, D.S., Chapple, S.N., Price, E.P., Matthew, M.M., Holden, T.G., Peacock, S.J. y Currie, B.J., “Whole-genome sequence to investigate a non-clonal melioidosis cluster on a remote Australian island”, Microbial Genomics, 2017, 3: 1-7.

  3. Mukhopadhyay, C., Eshwara, V.K., Kini, P. y Bhat, V., “Pediatric melioidosis in Southern India”, Indian Pediatr, 2015, 52: 711-712.

  4. Baker, C.J., Red Book. Atlas of pediatric infectious diseases. 3ª ed., American Academy of Pediatrics, 2015.

  5. Hayden, H.S. et al., “Evolution of Burkholderia pseudomallei in recurrent melioidosis, plos One, 2012, 7: e36507, disponible en: https://doi.org/10.1371/journal. pone.0036507.

  6. Price, E.P. et al., “Within-host evolution of Burkholderia pseudomallei in four cases of acute melioidosis, plos Pathog, 2010, 6: e1000725, disponible en: https://doi. org/10.1371/journal.ppat.1000725.

  7. Lever, M.S. et al., “Experimental aerogenic Burkholderia mallei (glanders) infection in the balb/c mouse”, J Med Microbiol, 2003, 52: 1109-1115.

  8. Zeeshan, M., Aziz, T. y Naqvi, F., “Recurrent urinary tract infection by Burkholderia cepacia in a live related renal transplant recipient”, J Pak Med Assoc, 2012, 62: 496-498.

  9. De Souza, A. et al., “Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience”, J Heart Lung Transplant, 2010, 29: 1395-1404.

  10. Gilad, J., Schwartz, D. y Amsalem, Y., “Clinical features and laboratory diagnosis of infection with the potential bioterrorism agents Burkholderia mallei and Burkholderia pseudomallei, ijbs, 2007, 3 (3): 144-152.

  11. Singh, M. y Mahmood, M., “Melioidosis: the great mimicker”, J Community Hosp Intern Med Perspect, 2017, 7 (4): 245-247.

  12. Hoffmaster, A.R., Aucoin, D., Baccam, P. et al., “Melioidosis diagnostic workshop, 2013”, Emerg Infect Dis, 2015, 21 (2): e141045.

  13. Merritt, A.J. y Inglis, T.J.J., “The role of climate in the epidemiology of melioidosis”, Curr Trop Med Rep, 2017, 4 (4): 185-191.

  14. Currie, B.J., Burkholderia pseudomallei and Burkholderia mallei: melioidosis and glanders, en Bennett, J.E., Dolin, R. y Blaser, M.J. (eds.), Mandell, Douglas, and Bennett’s principles and practice of infectious diseases, PA, Elsevier Saunders, 2015, pp. 2541-2551.

  15. Stewart, T., Engelthaler, D.M., Blaney, D.D. et al., “Epidemiology and investigation of melioidosis, Southern Arizona”, Emerg Infect Dis, 2011, 17: 1286-1288.

  16. Centers for Disease Control and Prevention (cdc), “Imported melioidosis–South Florida, 2005”, mmwr Morb Mortal Wkly Rep, 2006, 55: 873.

  17. Yee, K.C., Lee, M.K., Chua, C.T. et al., “Melioidosis, the great mimicker: a report of 10 cases from Malaysia”, J Trop Med Hyg, 1988, 91: 249-254.

  18. Bandeira, T.J.P.G., Castelo-Branco, D.S.C.M., Rocha, M.F.G., Cordeiro, R.A., Ocadaque, C.J., Paiva, M.A.N., Brilhante, R.S.N. y Sidrim, J.J.C., “Clinical and environmental isolates of Burkholderia pseudomallei from Brazil: genotyping and detection of virulence gene”, Asian Pac J Trop Med, 2017, 10 (10): 945-951.

  19. Wiersinga, W.J., Currie, B.J. y Peacock, S.J., “Melioidosis”, N Engl J Med, 2012, 367: 1035-1044.

  20. Robertson, J., Levy, A., Sagripanti, J.L. e Inglis, T.J.J., “The survival of Burkholderia pseudomallei in liquid media”, Am J Trop Med Hyg, 2010, 82: 88-94.

  21. Peacock, S.J., Schweizer, H.P., Dance, D.A., Smith, T.L., Gee, J.E., Wuthiekanun, V. et al., “Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei”, Emerg Infect Dis, 2008, 14: e2.

  22. John, T.J., Jesudason, M.V., Lalitha, M.K., Ganesh, A., Mohandas, V., Cherian, T. et al., “Melioidosis in India: the tip of the iceberg?”, Indian J Med Res, 1996, 103: 62-65.

  23. Ngauy, V., Lemeshev, Y., Sadkowski, L. y Crawford, G., “Cutaneous melioidosis in a man who was taken as a prisoner of war by the Japanese during World War II”, J Clin Microbiol, 2005; 43: 970-972.

  24. Kibbler, C.C., Roberts, C.M., Ridgway, G.L. y Spiro, S.G., “Melioidosis in a patient from Bangladesh”, Postgrad Med J, 1991, 67: 764-766.

  25. Pumpuang, A. et al., “Survival of Burkholderia pseudomallei in distilled water for 16 years”, Trans R Soc Trop Med Hyg, 2011, 105: 598-600.

  26. Gal, D. et al., “Contamination of hand wash detergent linked to occupationally acquired meliodosis”, Am J Trop Med Hyg, 2004, 71: 360-362.

  27. Dejsirilert, S., Kondo, E., Chiewsilp, D. y Kanai, K., “Growth and survival of Pseudomonas pseudomallei in acidic environments”, Jpn J Med Sci Biol, 1991, 44: 63-74.

  28. Chen, Y.S., Chen, S.C., Kao, C.M. y Chen, Y.L., “Effects of soil pH, temperature and water content on the growth of Burkholderia pseudomallei”, Folia Microbiol, 2003, 48: 253-256.

  29. Ainsworth, R. (ed.), Safe piped water: managing microbial water quality in piped distribution systems, Londres- Ginebra, iwa Publishing-Organización Mundial de la Salud, Londres-Ginebra, 2004.

  30. Currie, B.J., Fisher, D.A., Howard, D.M., Burrow, J.N., Selvanayagam, S., Snelling, P.L., Anstey, N.M. y Mayo, M.J., “The epidemiology of melioidosis in Australia and Papua New Guinea”, Acta Trop, 2000, 74 (2-3): 121-127.

  31. Currie, B.J. et al., “A cluster of melioidosis cases from an endemic region is clonal and is linked to the water supply using molecular typing of Burkholderia pseudomallei isolates”, Am J Trop Med Hyg, 2001, 65: 177-179.

  32. Inglis, T.J. et al., “Outbreak strain of Burkholderia pseudomallei traced to water treatment plant”, Emerg Infect Dis, 2000, 6: 56-59.

  33. Dance, D.A., Wuthiekanun, V., Naigowit, P. y White, N.J., “Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and api 20ne”, J Clin Pathol, 1989, 42: 645-648.

  34. Limmathurotsakul, D., Jamsen, K., Arayawichanont, A., Simpson, J.A., White, L.J., Lee, S.J. et al., “Defining the true sensitivity of culture for the diagnosis of melioidosis using Bayesian latent class models”, plos One, 2010, 5: e12485.

  35. Roesnita, B., Tay, S.T., Puthucheary, S.D. y Sam, I.C., “Diagnostic use of Burkholderia pseudomallei selective media in a low prevalence setting”, Trans R Soc Trop Med Hyg, 2012, 106: 131-133.

  36. Tandhavanant, S., Wongsuvan, G., Wuthiekanun, V., Teerawattanasook, N., Day, N.P., Limmathurotsakul, D. et al., “Monoclonal antibody-based immunofluorescence microscopy for the rapid identification of Burkholderia pseudomallei in clinical specimens”, Am J Trop Med Hyg, 2013, 89: 165-168.

  37. Wongsuvan, G., Limmathurotsakul, D., Wannapasni, S., Chierakul, W., Teerawattanasook, N. y Wuthiekanun, V., “Lack of correlation of Burkholderia pseudomallei quantities in blood, urine, sputum and pus”, Southeast Asian J Trop Med Public Health, 2009, 40: 781-784.

  38. Dance, D.A., Wuthiekanun, V., Naigowit, P. y White, N.J., “Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and api 20ne”, J Clin Pathol, 1989, 42: 645-648.

  39. Tandhavanant, S., Wongsuvan, G., Wuthiekanun, V., Teerawattanasook, N., Day, N.P., Limmathurotsakul, D. et al., “Monoclonal antibody-based immunofluorescence microscopy for the rapid identification of Burkholderia pseudomallei in clinical specimens”, Am J Trop Med Hyg, 2013, 89: 165-168.

  40. Inglis, T.J., Chiang, D., Lee, G.S. y Chor-Kiang, L., “Potential misidentification of Burkholderia pseudomallei by api 20ne”, Pathology, 1998, 30: 62-64.

  41. Lowe, P., Engler, C. y Norton, R., “Comparison of automated and nonautomated systems for identification of Burkholderia pseudomallei”, J Clin Microbiol, 2002, 40: 4625-4627.

  42. Inglis, T.J., Merritt, A., Chidlow, G., Aravena-Roman, M. y Harnett, G., “Comparison of diagnostic laboratory methods for identification of Burkholderia pseudomallei”, J Clin Microbiol, 2005, 43: 2201-2206.

  43. Dickinson, B., “BD Phoenix system user’s manual”, document L003342(M), Becton Dickinson and Company, Sparks, MD, 2005.

  44. BioMérieux, “Vitek 2 product information”, document 510769-4EN1, BioMérieux, Inc., Durham, NC, 2006.

  45. Glass, M.B. y Popovic, T., “Preliminary evaluation of the api 20ne and Rapid nf plus systems for rapid identification of Burkholderia pseudomallei and B. mallei”, J Clin Microbiol, 2005, 43: 479-483.

  46. Amornchai, P., Chierakul, W., Wuthiekanun, V., Mahakhunkijcharoen, Y., Phetsouvanh, R., Currie, B.J. et al., “Accuracy of Burkholderia pseudomallei identification using the api 20ne system and a latex agglutination test”, J Clin Microbiol, 2007, 45: 3774-3776.

  47. Koh, T.H., Yong, Ng, L.S., Foon Ho, J.L., Sng, L.H., Wang, G.C. y Tzer Pin Lin, R.V., “Automated identification systems and Burkholderia pseudomallei, J Clin Microbiol, 2003, 41: 1809.

  48. Weissert, C., Dollenmaier, G., Rafeiner, P., Riehm, J. y Schultze, D. “Burkholderia pseudomallei misidentified by automated system”, Emerg Infect Dis, 2009, 15: 1799-1801.

  49. Lowe, P., Haswell, H. y Lewis, K., “Use of various common isolation media to evaluate the new Vitek 2 colorimetric gn card for identification of Burkholderia pseudomallei”, J Clin Microbiol, 2006, 44: 854-856.

  50. Zong, Z., Wang, X., Deng, Y. y Zhou, T., “Misidentification of Burkholderia pseudomallei as Burkholderia cepacia by the Vitek 2 system”, J Med Microbiol, 2012, 61: 1483- 1484.

  51. Podin, Y., Kaestli, M., McMahon, N., Hennessy, J., Ngian, H.U., Wong, J.S, et al., “Reliability of automated biochemical identification of Burkholderia pseudomallei is regionally dependent”, J Clin Microbiol, 2013, 51: 3076-3078.

  52. Hodgson, K., Engler, C., Govan, B., Ketheesan, N. y Norton, R., “Comparison of routine bench and molecular diagnostic methods in identification of Burkholderia pseudomallei”, J Clin Microbiol, 2009, 47: 1578-1580.

  53. Podin, Y., Sarovich, D.S., Price, E.P., Kaestli, M., Mayo, M., Hii, K. et al., “Burkholderia pseudomallei isolates from Sarawak, Malaysian Borneo, are predominantly susceptible to aminoglycosides and macrolides”, Antimicrob Agents Chemother, 2014, 58: 162-166.

  54. Anuntagool, N., Naigowit, P., Petkanchanapong, V., Aramsri, P., Panichakul, T. y Sirisinha, S., “Monoclonal antibodybased rapid identification of Burkholderia pseudomallei in blood culture fluid from patients with community-acquired septicaemia”, J Med Microbiol, 2000, 49: 1075-1078.

  55. Cheng, A.C., O’Brien, M., Freeman, K., Lum, G. y Currie, B.J., “Indirect hemagglutination assay in patients with melioidosis in northern Australia”, Am J Trop Med Hyg, 2006, 74: 330-334.

  56. Cheng, A.C., Peacock, S.J., Limmathurotsakul, D., Wongsuvan, G., Chierakul, W., Amornchai, P. et al., “Prospective evaluation of a rapid immunochromogenic cassette test for the diagnosis of melioidosis in northeast Thailand”, Trans R Soc Trop Med Hyg, 2006, 100: 64-67.

  57. Harris, P.N., Ketheesan, N., Owens, L. y Norton, R.E., “Clinical features that affect indirect-hemagglutination-assay responses to Burkholderia pseudomallei”, Clin Vaccine Immunol, 2009, 16: 924-930.

  58. Chantratita, N., Tandhavanant, S., Wongsuvan, G., Wuthiekanun, V., Teerawattanasook, N., Day, N.P. et al., “Rapid detection of Burkholderia pseudomallei in blood cultures using a monoclonal antibody-based immunofluorescent assay”, Am J Trop Med Hyg, 2013, 89: 971-972.

  59. Wuthiekanun, V., Desakorn, V., Wongsuvan, G., Amornchai, P., Cheng, A.C., Maharjan, B. et al., “Rapid immunofluorescence microscopy for diagnosis of melioidosis”, Clin Diagn Lab Immunol, 2005, 12: 555-556.

  60. Ortega, G.M.V. et al., “pcr cuantitativa en tiempo real para la amplificación de adn de Burkholderia mallei: comparación con el método molecular recomendado por la oie”, Said Mil, 2017, 73 (2): 85-90.

  61. Tomaso, H., Scholz, H.C., Al Dahouk, S., Eickhoff, M., Treu, T.M. et al., “Development of a 59-nuclease realtime pcr assay targeting flip for the rapid identification of Burkholderia mallei in clinical samples”, Clin Chem, 2006, 52: 307-310.

  62. Ordóñez, R.I., Otero, M.F., Arias, G.E., Pérez, G.E. y Corcuera, D.C., “Choque séptico por Burkholderia multivorans en paciente previamente sano a su ingreso hospitalario. Presentación de un caso y revisión de la literatura”, trabajo libre presentado en el XXXV Congreso de Infectología Pediátrica, Asociación Mexicana de Infectología Pediátrica, Veracruz 2016.

  63. Gilad, J., Schwartz, D. y Amsalem, Y., “Clinical features and laboratory diagnosis of infection with the potential bioterrorism agents Burkholderia Mallei and Burkholderia pseudomallei”, Inter J Biomed Science, 2007, 3 (3): 144-152.




2020     |     www.medigraphic.com